134 related articles for article (PubMed ID: 8552672)
1. Inhibition of Plasmodium falciparum malaria using antisense oligodeoxynucleotides.
Barker RH; Metelev V; Rapaport E; Zamecnik P
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):514-8. PubMed ID: 8552672
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium falciparum: effect of chemical structure on efficacy and specificity of antisense oligonucleotides against malaria in vitro.
Barker RH; Metelev V; Coakley A; Zamecnik P
Exp Parasitol; 1998 Jan; 88(1):51-9. PubMed ID: 9501848
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles.
Föger F; Noonpakdee W; Loretz B; Joojuntr S; Salvenmoser W; Thaler M; Bernkop-Schnürch A
Int J Pharm; 2006 Aug; 319(1-2):139-46. PubMed ID: 16713146
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Plasmodium falciparum proliferation in vitro by antisense oligodeoxynucleotides against malarial topoisomerase II.
Noonpakdee W; Pothikasikorn J; Nimitsantiwong W; Wilairat P
Biochem Biophys Res Commun; 2003 Mar; 302(4):659-64. PubMed ID: 12646219
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligonucleotides targeting malarial aldolase inhibit the asexual erythrocytic stages of Plasmodium falciparum.
Wanidworanun C; Nagel RL; Shear HL
Mol Biochem Parasitol; 1999 Jul; 102(1):91-101. PubMed ID: 10477179
[TBL] [Abstract][Full Text] [Related]
6. Hybridization arrest of cell-free translation of the malarial dihydrofolate reductase/thymidylate synthase mRNA by anti-sense oligodeoxyribonucleotides.
Sartorius C; Franklin RM
Nucleic Acids Res; 1991 Apr; 19(7):1613-8. PubMed ID: 2027768
[TBL] [Abstract][Full Text] [Related]
7. [Plasmodium falciparum: antimalarial activities of antisense oligodeoxyribonucleotides targeted to histidine-rich protein genes in vitro].
Yu XB; Fang JM; Luo SH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(4):200-3. PubMed ID: 12567657
[TBL] [Abstract][Full Text] [Related]
8. Anti-sense oligodeoxynucleoside phosphorothioates nonspecifically inhibit invasion of red blood cells by malaria parasites.
Ramasamy R; Kanagaratnam R; Misiura K; Rebowski G; Amerakoon R; Stec WJ
Biochem Biophys Res Commun; 1996 Jan; 218(3):930-3. PubMed ID: 8579616
[TBL] [Abstract][Full Text] [Related]
9. Non-sequence-specific antimalarial activity of oligodeoxynucleotides.
Clark DL; Chrisey LA; Campbell JR; Davidson EA
Mol Biochem Parasitol; 1994 Jan; 63(1):129-34. PubMed ID: 8183311
[TBL] [Abstract][Full Text] [Related]
10. Malaria merozoite surface protein antisense oligodeoxynucleotides lack antisense activity but function as polyanions to inhibit red cell invasion.
Kanagaratnam R; Misiura K; Rebowski G; Ramasamy R
Int J Biochem Cell Biol; 1998 Sep; 30(9):979-85. PubMed ID: 9785462
[TBL] [Abstract][Full Text] [Related]
11. Antisense oligodeoxynucleotides: useful tool for search and assessment of new targets for anti-malarial drugs.
Ikemoto N; Kim HS; Kanazaki M; Ueno Y; Shuto S; Matsuda A; Wataya Y
Nucleic Acids Symp Ser; 1999; (42):89-90. PubMed ID: 10780393
[TBL] [Abstract][Full Text] [Related]
12. Is antisense an appropriate nomenclature or design for oligodeoxynucleotides aimed at the inhibition of HIV-1 replication?
Lavigne C; Yelle J; Sauve G; Thierry AR
AAPS PharmSci; 2002; 4(2):E9. PubMed ID: 12102618
[TBL] [Abstract][Full Text] [Related]
13. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.
Morishita R; Gibbons GH; Ellison KE; Nakajima M; Zhang L; Kaneda Y; Ogihara T; Dzau VJ
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8474-8. PubMed ID: 8104336
[TBL] [Abstract][Full Text] [Related]
14. Hairpin extensions enhance the efficacy of mycolyl transferase-specific antisense oligonucleotides targeting Mycobacterium tuberculosis.
Harth G; Zamecnik PC; Tabatadze D; Pierson K; Horwitz MA
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7199-204. PubMed ID: 17438292
[TBL] [Abstract][Full Text] [Related]
15. Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.
Wu AG; Joshi SS; Chan WC; Iversen PL; Jackson JD; Kessinger A; Pirruccello SJ; Sanger WG; Sharp JG; Verbik DJ
Leuk Lymphoma; 1995 Dec; 20(1-2):67-76. PubMed ID: 8750625
[TBL] [Abstract][Full Text] [Related]
16. Cloning, sequence determination, and regulation of the ribonucleotide reductase subunits from Plasmodium falciparum: a target for antimalarial therapy.
Rubin H; Salem JS; Li LS; Yang FD; Mama S; Wang ZM; Fisher A; Hamann CS; Cooperman BS
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9280-4. PubMed ID: 8415692
[TBL] [Abstract][Full Text] [Related]
17. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.
Williams SA; Chang L; Buzby JS; Suen Y; Cairo MS
Leukemia; 1996 Dec; 10(12):1980-9. PubMed ID: 8946941
[TBL] [Abstract][Full Text] [Related]
18. [An EGFR antisense oligodeoxynucleotides and its phosphorothioate analogue inhibit the growth of human hepatocarcinoma BEL-7404 cells].
Lin JQ; Xu ZS; Zhang HY; Yang ZW; Xu YH
Shi Yan Sheng Wu Xue Bao; 1995 Sep; 28(3):241-6. PubMed ID: 8571707
[TBL] [Abstract][Full Text] [Related]
19. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
Bamaga OA; Mahdy MA; Lim YA
Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
[TBL] [Abstract][Full Text] [Related]
20. Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replication.
Lavigne C; Yelle J; Sauvé G; Thierry AG
AAPS PharmSci; 2001; 3(1):E7. PubMed ID: 11741258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
